IL1B and Alzheimer disease: Moreover, IL-1β release, NLRP3 activation, and consequent neuroinflammation were reduced when AD transgenic mice were treated with mefenamic acid, which belongs to the nonsteroidal anti-inflammatory class of drugs [68].